Brief: Xbrane Biopharma Introduces Cost-Savings Scheme
23/11/2023 10:18
Nov 23 (Reuters) - Xbrane Biopharma AB XBRANE.ST :
* IS FOCUSING THE DEVELOPMENT PORTFOLIO AND INTRODUCING A
COST-SAVINGS SCHEME
* A COST-SAVINGS SCHEME IS BEING INTRODUCED WHICH IS
EXPECTED TO
RESULT IN AROUND SEK 50 MILLION IN ANNUAL SAVINGS WHEN FULLY
IMPLEMENTED
* SAVINGS TAKE PLACE IN ALL AREAS AND INCLUDE STAFF
REDUCTIONS
TOTALING ABOUT 40 POSITIONS, INCLUDING BOTH PERMANENT STAFF AND
CONSULTANTS
* SAVINGS ARE REALIZED GRADUALLY AND ARE EXPECTED TO BE
FULLY
IMPLEMENTED IN Q3 2024
Source text for Eikon: ID:nMFNbTQSBD
Further company coverage: XBRANE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))